Stryker, Johnson & Johnson’s DePuy Synthes and Zimmer Biomet are the largest orthopedic device companies. With elective procedure numbers rebounding after the darkest days of the COVID-19 pandemic, sales at most of the world’s largest orthopedic device companies increased by double-digit percentages during their most recent fiscal years. Here are the world’s 10 largest orthopedic […]
Orthofix
Orthofix lowers full-year revenue guidance on missed Q2 results
Orthofix (Nasdaq:OFIX) this week reported second-quarter results that missed the overall consensus on Wall Street. The Lewisville, Texas-based orthopedic device maker reported profits of $2.5 million, or 12¢ per share, on sales of $118.1 million for the three months ended June 30, for a bottom-line gain of 2.9% on sales loss of 2.74%. Adjusted to […]
Orthofix partners with LimaCorporate on hip dislocation solution
Orthofix Medical (Nasdaq:OFIX) announced today that it entered into a licensing partnership for the U.S. market with LimaCorporate. The licensing partnership aims to provide a novel solution for patients with the challenging condition of chronic high dislocation of the hip. It will combine the limb-lengthening technology of Orthofix’s Fitbone intramedullary nail system with LimaCorporate’s proprietary, […]
Orthofix announces 5-year positive data for its M6-C artificial cervical disc
Orthofix Medical (Nasdaq:OFIX) today announced positive five-year data from the single-level IDE study of its M6-C artificial cervical disc. Lewisville, Texas–based Orthofix will hold a presentation of the data on June 3 at the International Society for the Advancement of Spine Surgery annual meeting in Nassau, Bahamas. It’s been more than three years since FDA […]
Orthofix beats The Street in Q1, reaffirms 2022 guidance
Orthofix (Nasdaq:OFIX) recorded first-quarter financial results that came in ahead of the consensus forecast on Wall Street. The Lewisville, Texas-based orthopedic implant company posted losses of $4.5 million, or 22¢ per share, on sales of $106.4 million for the three months ended March 31, 2022, for a slight bottom-line gain closer to breakeven on sales […]
Orthofix wins FDA PMA for bone growth stimulation device
Orthofix (Nasdaq:OFIX) announced today that it received FDA premarket approval (PMA) for its AccelStim bone healing therapy device. Lewisville, Texas-based Orthofix designed the AccelStim device to provide a safe and effective nonsurgical treatment for indicated fresh fractures and for fractures that have not healed (nonunions). According to a news release, the device generates a low-intensity […]
Orthofix names Kimberley Elting as orthopedics business president
Orthofix (NSDQ:OFIX) today announced it appointed Kimberley Elting to president of the global orthopedics business, effective immediately. Elting, who most recently was the company’s chief legal and development officer, will succeed Paul Gonsalves who is pursuing other opportunities. “With more than 25 years in the medical device space, a track record of success at Orthofix, […]
FDA clears Orthofix TrueLok Evo Ring fixation system
Orthofix today announced that it received FDA 510(k) clearance for its TrueLok Evo Ring Fixation system. The Lewisville, Texas-based orthopedics company designed the device for complex limb reconstruction and deformity correction procedures. It is a circular fixator with radiolucent rings and struts for clear radiographic visualization, allowing physicians to better assess bone anatomy during and […]
Orthofix beats The Street in Q4
Orthofix (NSDQ:OFIX) today posted fourth-quarter results that beat the overall consensus on Wall Street. The Lewisville, Texas-based orthopedic device maker reported losses of $32.8 million, or $1.65 per share, on sales of $125.1 million, for the three months ended Dec. 31, 2021. Sales were up 6.33% compared with Q4 2020. Adjusted to exclude one-time items, […]
Intersect ENT CEO joins Orthofix board
Orthofix (NSDQ:OFIX) announced today that Intersect ENT (NSDQ:XENT) executive Thomas A. West has joined its board of directors. Lewisville, Texas-based Orthofix named West to its board and appointed him to its Compensation and Talent Development Committee. West currently serves as President, CEO & Director of Intersect ENT, which develops drug-delivery devices for ear, nose and […]
Orthofix ticks up on Street-beating Q2 results
Orthofix (NSDQ:OFIX) posted second-quarter results today that beat the overall consensus on Wall Street. The Lewisville, Texas-based company reported profits of $2.4 million, or 12¢ per share, on sales of $121.4 million, for the three months ended June 30 for a sales growth of 65.99% compared with Q2 2020. Adjusted to exclude one-time items, earnings per […]
